$2.38
1.93% today
Nasdaq, Feb 05, 04:45 pm CET
ISIN
US0043971052
Symbol
ARAY

Accuray Incorporated Stock price

$2.33
+0.14 6.39% 1M
+0.86 58.50% 6M
+0.35 17.68% YTD
-0.05 2.10% 1Y
-1.28 35.46% 3Y
-1.29 35.64% 5Y
-5.33 69.58% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+0.14 6.39%
ISIN
US0043971052
Symbol
ARAY
Sector

Key metrics

Market capitalization $234.32m
Enterprise Value $383.42m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.86
P/S ratio (TTM) P/S ratio 0.53
P/B ratio (TTM) P/B ratio 5.17
Revenue growth (TTM) Revenue growth -2.37%
Revenue (TTM) Revenue $444.20m
EBIT (operating result TTM) EBIT $-3.86m
Free Cash Flow (TTM) Free Cash Flow $-14.24m
Cash position $59.69m
EPS (TTM) EPS $-0.17
P/E forward negative
P/S forward 0.50
EV/Sales forward 0.82
Short interest 4.10%
Show more

Is Accuray Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Accuray Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Accuray Incorporated forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Accuray Incorporated forecast:

Buy
100%

Financial data from Accuray Incorporated

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
444 444
2% 2%
100%
- Direct Costs 306 306
3% 3%
69%
138 138
13% 13%
31%
- Selling and Administrative Expenses 88 88
2% 2%
20%
- Research and Development Expense 48 48
16% 16%
11%
2.26 2.26
81% 81%
1%
- Depreciation and Amortization 6.12 6.12
33% 33%
1%
EBIT (Operating Income) EBIT -3.86 -3.86
151% 151%
-1%
Net Profit -17 -17
143% 143%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Accuray Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Accuray Incorporated Stock News

Neutral
PRNewsWire
13 days ago
MADISON, Wis. , Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built in China through the CNNC-Accuray joint venture.
Neutral
PRNewsWire
14 days ago
MADISON, Wis. , Jan. 22, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2025, ended December 31, 2024, during a conference call hosted by company management at 1:30 p.m.
Neutral
PRNewsWire
15 days ago
MADISON, Wis. , Jan. 21, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Leonel Peralta is joining the company as Senior Vice President, Chief Operations Officer, effective February 3, 2025.
More Accuray Incorporated News

Company Profile

Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Suzanne Winter
Employees 987
Founded 1990
Website www.accuray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today